Therapy for advanced cholangiocarcinoma: Current knowledge and future potential-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapy for advanced cholangiocarcinoma: Current knowledge and future potential

Published:2020-12-04 Issue:2 Volume:25 Page:618-628
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Wang Mingxun¹,Chen Ziyan¹,Guo Pengyi²,Wang Yi³^ORCID,Chen Gang¹^ORCID

Affiliation:

1. Department of Hepatobiliary Surgery The First Affiliated Hospital, Wenzhou Medical University Wenzhou China

2. Department of Cardiothoracic Surgery Ningbo Yinzhou NO.2 Hospital Ningbo China

3. Department of Epidemiology and Biostatistics, Public Health and Management School Wenzhou Medical University Wenzhou China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16151

Reference109 articles.

1. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

2. The 2019 WHO classification of tumours of the digestive system

3. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline

4. New Horizons for Precision Medicine in Biliary Tract Cancers

5. Advances in the treatment of metastatic or unresectable biliary tract cancer

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Inhibition of PI3 Kinase and MAP Kinase Signaling Pathways in Intrahepatic Cholangiocellular Carcinoma Cell Lines Leads to Proliferation Arrest but Not Apoptosis;Current Issues in Molecular Biology;2024-07-13

2. Promotion of perineural invasion of cholangiocarcinoma by Schwann cells via nerve growth factor;Journal of Gastrointestinal Oncology;2024-06

3. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment;World Journal of Surgical Oncology;2024-04-25

4. Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review;Surgery Today;2024-04-02

5. Ex vivo liver resection and auto-transplantation and special systemic therapy in perihilar cholangiocarcinoma treatment;World Journal of Gastrointestinal Surgery;2024-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3